Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Trypanothione as a Target in the Design of Antitrypanosomal and Antileishmanial Agents

Author(s): K. Augustyns, K. Amssoms, A. Yamani, P. K. Rajan and A. Haemers

Volume 7, Issue 12, 2001

Page: [1117 - 1141] Pages: 25

DOI: 10.2174/1381612013397564

Price: $65

Open Access Journals Promotions 2
Abstract

Trypanothione is the key molecule in the defence mechanism of Trypanosoma and Leishmania against oxidative stress. The uniqueness of trypanothione makes the metabolism of this molecule an attractive target in antitrypanosomal and antileishmanial drug design. It became clear that this antioxidant cascade can be considered as the Achilles heel of these parasites. The following targets and their respective inhibitors will be discussed biosynthesis of trypanothione with glutathionylspermidine synthetase and trypanothione synthetase biosynthesis of glutathione with gama-glutamylcysteine synthetase biosynthesis of spermidine with ornithine decarboxylase trypanothione hydroperoxide metabolism with tryparedoxine peroxidase, tryparedoxine and trypanothione reductase.

Keywords: Trypanothione, Antitrypanosomal, Antileishmanial Agents, oxidative stress, glutathionylspermidine synthetase, trypanothione synthetase, g-glutamylcysteine, spermidine, ornithine, decarboxylase


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy